What triggered the 26.73% pre-market rise in 8143.HK stock?

The jump appears volume-driven; **1,580,000** shares traded versus average **1,153,059**. No confirmed company news was released, so the move likely reflects sentiment and liquidity in a thin small-cap healthcare name.

How does Meyka AI grade 8143.HK stock and what does it mean?

Meyka AI rates 8143.HK **62.52/100**, Grade **B**, Suggestion **HOLD**. The grade combines benchmark, sector, financial growth, key metrics, and forecasts. It is informational and not investment advice.

What is the short-term price forecast for 8143.HK stock?

Meyka AI's forecast model projects a quarterly level near **HK$0.18**, implying roughly **40.63%** upside from **HK$0.128**. Forecasts are projections and not guarantees.

Are there major valuation concerns for 8143.HK stock?

Yes. EPS is **-0.03**, price-to-book is **7.86**, and free cash flow per share is small. These metrics signal elevated valuation versus tangible equity and higher risk for long-term holders.

HK Stocks

Up 26.73% pre-market 13 Mar 2026: Good Fellow Healthcare 8143.HK (HKSE) rally

ByHuzaifa Zahoor March 12, 2026

We start pre-market on 13 Mar 2026 with 8143.HK stock up 26.73%, trading at HK$0.128 after a large volume spike of 1,580,000 shares. The move leads Hong Kong small-cap healthcare winners and follows higher intraday range, with a day low at HK$0.122 and day high at HK$0.135. Traders will watch liquidity and sector context, because the Healthcare sector is underperforming month-to-date, creating a short-term trade environment for momentum strategies.